Back to results
US 2014/0274889 A1Published application
Cardio- and renoprotective antidiabetic therapy
AssigneeBoehringer Ingelheim International GmbH
InventorsOdd-Erik JOHANSEN, Maximilian VON EYNATTEN, Thomas KLEIN, Hans-Juergen WOERLE
Life of this patent
Estimating the term…
Abstract
The present invention relates to a certain DPP-4 inhibitor for use in cardio- and/or renoprotective therapy, including in patients at high vascular risk.
Claims23
A method of using linagliptin, or a pharmaceutically acceptable salt thereof, in therapy of a patient having or being at-risk of cardiovascular and/or renal microvascular disease, the method comprising administering linagliptin, or a pharmaceutically acceptable salt thereof, optionally in combination with one or more other active agents, to said patient
Dependencies are inferred from the claim text.